Brief Behavioral Activation Treatment for Depression With Inpatients

Lovisenberg Diakonale Hospital

Status: Completed

Conditions: Depression

Treatments: Other: Standard Care; Behavioral: Brief Behavioral Activation Treatment for Depression

Study type: Interventional

Funder types: Other

Identifiers

NCT02712918

BATD_16674

Details and patient eligibility

About

The purpose of the current study was to examine Brief Behavioral Activation Treatment for Depressions (BATD) effectiveness, credibility, and acceptability with moderate to severly depressed inpatients. The study is a systematic replication of a randomized controlled trail from 2003, that provided initial support for BATD With inpatients. The current study compared BATD to Treatment as Usual in a randomized controlled trial.

Enrollment: 23 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Moderate to severe depression (BDI-II > 28 Points).
• Admission length of at least 3 days
• Evaluated to benefit from depression treatment by unit psychiatrist.

Exclusion criteria

• Current psychotic disorder
• Previously diagnosis with psychotic disorder (including Bipolar disorder)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

23 participants in 2 patient groups, including a placebo group

Brief Behavioral Activation Treatment for Depression

Experimental group

Description:

Behavioral treatment of depression. The study utilized the revised version of the Brief Behavioral Activation Treatment for Depression (BATD) protocol from 2011. The treatment was added to treatment as usual. Up to 10 sessions were administered.

Treatment:

Behavioral: Brief Behavioral Activation Treatment for Depression

Standard care

Placebo Comparator group

Description:

Standard CARE (SC) at the inpatient unit. Mandatory: Therapeutic conversations with psychiatrist, psychologist or M.D, milieu therapy. Optional: Psychosomatic physiotherapy, therapeutic groups, psychopharmacological treatment.

Treatment:

Other: Standard Care